Skip to content

Management of Bronchial Asthma with Varma points manipulation and Internal medicine Muppalai Chooranam

AN OPEN LABELLED DOUBLE ARM NON-RANDOMIZED,PHASE-II CLINICAL TRIAL TO COMPARE THE EFFECTIVENESS OF VARMA POINTS MANIPULATION WITH MUPPALAI CHOORANAM(INTERNAL) IN THE MANAGEMENT OF SWASAKASAM (BRONCHIAL ASTHMA) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106668
Enrollment
40
Registered
2026-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

Intervention1: Varma point manipulation: Stimulation of specified varma points for 24 days Control Intervention1: Internal medicine Muppalai chooranam: 2gram of chooranam twice daily with honey for 24

Sponsors

Government Siddha Medical College and Hospital ,Palayamkottai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Adults who are diagnosed with bronchial asthma 2.Patients with a clinical symptoms of swasakasam-recurrent episodes of wheezing, chest tightness, shortness of breath and dry cough,worse at night or early morning. 3.History of symptoms triggered by allergens, climatic changes. 4.Patients willing to provide blood samples for laboratory investigations.

Exclusion criteria

Exclusion criteria: 1.Patients with pulmonary Tuberculosis 2.Patients with status asthmaticus 3.Patients with chronic bronchitis, chronic bronchiectasis 4.Patients with heart failure 5.Patients with renal disease 6.Pregnancy and Lactating mothers 7.Diabetes mellitus 8.Hypertension

Design outcomes

Primary

MeasureTime frame
Reduction in the severity and frequency of clinical symptoms of Swasakasam (Bronchial Asthma), including shortness of breath, chest tightness, wheezing, and dry cough Timepoint: 24 days

Secondary

MeasureTime frame
1.Evaluation of Asthma Control Questionnaire (ACQ) score following treatment 2.Evalaution of absolute eosinophil count following treatment Timepoint: 24 days

Countries

India

Contacts

Public ContactDr R KRISHNAMOORTHI MDS

Government Siddha Medical College and Hospital, Palayamkottai

arunaram1972@gmail.com9444206633

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026